intravenous immunoglobulin
-
Octapharma: New Consensus Recommendations on Treatment of Secondary Antibody Deficiency in Patients With Haematological Malignancies
LACHEN, Switzerland: New expert consensus guidelines on the use of immunoglobulin replacement therapy (IgRT) in patients with haematological malignancy and…
Read More » - Business
Positive Results From ProDERM Study of octagam® 10% in Patients With Dermatomyositis Meeting the Primary Endpoint Will Be Presented at ACR Convergence 2020
LACHEN, Switzerland: Octapharma announces that the final results from the phase III ProDERM study will be presented at the American…
Read More »